全文获取类型
收费全文 | 6797篇 |
免费 | 502篇 |
国内免费 | 94篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 196篇 |
妇产科学 | 165篇 |
基础医学 | 949篇 |
口腔科学 | 142篇 |
临床医学 | 736篇 |
内科学 | 1412篇 |
皮肤病学 | 122篇 |
神经病学 | 568篇 |
特种医学 | 472篇 |
外科学 | 662篇 |
综合类 | 151篇 |
一般理论 | 4篇 |
预防医学 | 676篇 |
眼科学 | 229篇 |
药学 | 426篇 |
中国医学 | 13篇 |
肿瘤学 | 413篇 |
出版年
2021年 | 100篇 |
2020年 | 51篇 |
2019年 | 94篇 |
2018年 | 102篇 |
2017年 | 79篇 |
2016年 | 75篇 |
2015年 | 89篇 |
2014年 | 117篇 |
2013年 | 202篇 |
2012年 | 248篇 |
2011年 | 291篇 |
2010年 | 210篇 |
2009年 | 200篇 |
2008年 | 240篇 |
2007年 | 293篇 |
2006年 | 282篇 |
2005年 | 298篇 |
2004年 | 294篇 |
2003年 | 282篇 |
2002年 | 254篇 |
2001年 | 182篇 |
2000年 | 183篇 |
1999年 | 170篇 |
1998年 | 160篇 |
1997年 | 144篇 |
1996年 | 151篇 |
1995年 | 132篇 |
1994年 | 145篇 |
1993年 | 131篇 |
1992年 | 128篇 |
1991年 | 149篇 |
1990年 | 134篇 |
1989年 | 121篇 |
1988年 | 130篇 |
1987年 | 121篇 |
1986年 | 127篇 |
1985年 | 101篇 |
1984年 | 79篇 |
1983年 | 75篇 |
1982年 | 77篇 |
1981年 | 69篇 |
1980年 | 78篇 |
1979年 | 59篇 |
1978年 | 74篇 |
1977年 | 75篇 |
1976年 | 62篇 |
1975年 | 39篇 |
1974年 | 56篇 |
1973年 | 49篇 |
1972年 | 40篇 |
排序方式: 共有7393条查询结果,搜索用时 31 毫秒
41.
42.
43.
Shirley A. Musich Alyssa B. Schultz Wayne N. Burton Dee W. Edington 《Disease Management & Health Outcomes》2004,12(5):299-326
Corporations have engaged in sponsorship of health management programs and, more recently, disease management programs to facilitate healthy and productive work environments. The purpose of this review is to examine the health and financial outcomes from these corporate-sponsored disease management programs. This article focuses on seven diseases or chronic conditions (arthritis, asthma, cancer, depression, diabetes mellitus, heart disease, and migraine) that potentially impact employee productivity (both in time away from work and in loss of effectiveness at work) and health status including medical and pharmaceutical utilization and costs.Corporate-sponsored disease management programs typically focus on education and screening for selected diseases or chronic conditions. Partnerships have been formed with health plans and third-party program providers to reach employees with interventions and treatment. The typical outcome measures from these programs have primarily been clinical indicators and medical utilization. Measures of productivity need to be incorporated as important outcome measures for disease management programs.The estimated financial opportunity for the corporation is a reflection of the cost differential for a given disease and the prevalence of that disease within the employee population. Primary diseases, chronic conditions, and health risks contribute to increased medical utilization and decreased productivity within the corporation. Promoting programs that focus on the whole person, including health risks, chronic conditions, and diseases, will likely increase the possibility of success in helping the employee to better self-manage their health conditions and consequently provide gains for both the individual and the corporation. 相似文献
44.
45.
46.
47.
48.
Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspectives 总被引:6,自引:0,他引:6
Gergory F. Burton Akihiro Masuda Sonya L. Heath Beverly A. Smith John G. Tew ras K. Szakal 《Immunological reviews》1997,156(1):185-197
Summary: Follicular dendritic cells (FDC) are found in the follicles of virtually all secondary lymphoid tissues. In health, these cells trap and retain antigens (Ag) in the form of immune complexes and preserve them for months in their native conformation. FDC thus serve as a long-term repository of extracellular Ag important for induction and maintenance of memory responses. In retroviral infection. FDC trap and retain large numbers of retroviral particles with profound effects on FDC. FDC-trapped retrovirus induces follicular hyperplasia, and conventional Ag trapped prior to infection are lost and new Ag cannot be trapped. Concomitantly, antibody-forming cells (AFC) specific for Ag lost from FDC decrease follow I by loss of specific serum antibody (Ab). Eventually, FDC die and follicular lysis occurs. From the pathogen perspective, binding to FDC is remarkably beneficial, bringing together virus and activated target cells that are highly susceptible to infection. Furthermore, FDC permit HIV to infect surrounding cells even in the presence of a vast excess of neutralizing Ab. Preliminary data suggest that FDC maintain virus infectivity - even when the virus cannot replicate. Thus retrovirus infection monopolizes FDC networks, thereby transforming the FDC Ag repository into a highly infectious retroviral reservoir. 相似文献
49.
In an attempt to establish an in vitro/in situ correlation of intestinal permeability data, the permeability coefficients (P
app) for a series of model peptides, which were determined using an in situ perfused rat ileum model, were compared to the permeability coefficients (P
mono) determined using an in vitro cell culture model (Caco-2). The model peptides, which were all blocked on the N-terminal (acetyl, Ac) and the C-terminal (amide, NH2) ends, consisted of D-phenylalanine (F) residues (e.g., AcFNH2, AcFFNH2, AcFFFNH2). To alter the degree of hydrogen bonding potential, the nitrogens of the amide bonds were sequentially methylated [e.g., AcFF(Me)FNH2, AcF(Me)F(Me)FNH2, Ac(Me)F(Me)F(Me)FNH2, Ac-(Me)F(Me)F(Me)FNH(Me)]. These peptides were shown not to be metabolized in the in situ perfused rat ileum system. The results of the transport experiments showed that there were poor correlations between the apparent permeability coefficients (P
app) determined in an in situ perfused rat ileum model and the octanol–water partition coefficients (r = 0.60) or the hydrogen bonding numbers (r = 0.63) of these peptides. However, good correlations were observed between the in situ
P
app values for these peptides and their partition coefficients in heptane–ethylene glycol (r = 0.96) and the differences in their partition coefficients between octanol–water and isooctane–water (r = 0.86). These results suggest that lipophilicity may not be the major factor in determining the intestinal permeability of these peptides and that hydrogen bonding potential may be a major contributing factor. A good correlation (r = 0.94) was also observed between the P
app values determined for these peptides in the in situ perfused ileum model and those P
mono values determined in the in vitro cell culture model (Caco-2) (Conradi et al., Pharm. Res. 8:1453–1460, 1991). These results suggest that the permeability values determined in the Caco-2 cell culture model may be a good predictor of the intestinal permeability of peptides. 相似文献
50.